July 14, 2020 ENZYCHEM LIFESCIENCES FILES IND APPLICATION TO FDA FOR PHASE 2 STUDY OF EC-18 IN PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) DUE TO COVID-19 PNEUMONIA Explore further
July 14, 2020 Enzychem files FDA Phase 2 study app to fight pneumonia due to COVID-19 – NJBIZ Explore further
